Naomi P. O'Grady
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Naomi P. O'Grady has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
Henry Masur
Critical Care Medicine Department, National Institutes of Health, Bethesda, Maryland
6 shared publications- Adrienne G. Randolph
Department of Anaesthesia and Pain Medicine, Boston Children’s Hospital, Harvard Medical School, Boston, MA
4 shared publications Leonard A. Mermel
Division of Infectious Diseases, Warren Alpert Medical School of Brown University and Rhode Island Hospital, Providence
4 shared publicationsMark E. Rupp
Department of Internal Medicine, University of Nebraska Medical Center, Omaha
4 shared publicationsMary Alexander
4 shared publicationsStephen O. Heard
Department of Anesthesiology, University of Massachusetts Medical School, Worcester
4 shared publications
Latest Publications
- 5 March 2024
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 79 (6) , 1537-1538
Society of Critical Care Medicine/Infectious Diseases Society of America (SCCM/IDSA) New Fever Guideline
Stanley C Deresinski, Naomi O’Grady; SCCM/IDSA New Fever Guideline Correspondence Letter, Clinical Infectious Diseases, , ciae118, https://doi.org/10.1093/cid/c
- 5 March 2024
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 79 (6) , 1537-1538
Society of Critical Care Medicine/Infectious Diseases Society of America (SCCM/IDSA) New Fever Guideline
Stanley C Deresinski, Naomi O’Grady; SCCM/IDSA New Fever Guideline Correspondence Letter, Clinical Infectious Diseases, , ciae118, https://doi.org/10.1093/cid/c
- 12 October 2023
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 51 (11) , 1566-1569
Executive Summary: Guidelines for Evaluating New Fever in Adult Patients in the ICU
- 12 October 2023
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 51 (11) , 1566-1569
Executive Summary: Guidelines for Evaluating New Fever in Adult Patients in the ICU
- 31 October 2022
- Published by Elsevier in Infectious Disease Clinics of North America
- Vol. 36 (4) , 735-748
Cytokine Release Syndrome and Sepsis
- 31 October 2022
- Published by Elsevier in Infectious Disease Clinics of North America
- Vol. 36 (4) , 735-748
Cytokine Release Syndrome and Sepsis
- 1 September 2017
- Published by Elsevier in Infectious Disease Clinics of North America
- Vol. 31 (3)
On the Interface of Infectious Diseases and Critical Care Medicine
- 1 September 2017
- Published by Elsevier in Infectious Disease Clinics of North America
- Vol. 31 (3)
On the Interface of Infectious Diseases and Critical Care Medicine
- 20 June 2012
- Published by American Medical Association (AMA) in JAMA
- Vol. 307 (23) , 2534-2539
Preventing Ventilator-Associated Pneumonia
Ventilator-associated pneumonia (VAP) is among the most common infections in patients requiring endotracheal tubes with mechanical ventilation. Ventilator-associated pneumonia is associated with increased hospital costs, a greater number of days in the intensive care unit, longer duration of mechanical ventilation, and higher mortality. Despite widely accepted recommendations for interventions designed to reduce rates of VAP, few studies have assessed the ability of these interventions to improve patient outcomes. As the understanding of VAP advances and new technologies to reduce VAP become available, studies should directly assess patient outcomes before the health care community implements specific prevention approaches in clinical practice.
- 20 June 2012
- Published by American Medical Association (AMA) in JAMA
- Vol. 307 (23) , 2534-2539
Preventing Ventilator-Associated Pneumonia
Ventilator-associated pneumonia (VAP) is among the most common infections in patients requiring endotracheal tubes with mechanical ventilation. Ventilator-associated pneumonia is associated with increased hospital costs, a greater number of days in the intensive care unit, longer duration of mechanical ventilation, and higher mortality. Despite widely accepted recommendations for interventions designed to reduce rates of VAP, few studies have assessed the ability of these interventions to improve patient outcomes. As the understanding of VAP advances and new technologies to reduce VAP become available, studies should directly assess patient outcomes before the health care community implements specific prevention approaches in clinical practice.
- 1 February 2012
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 40 (2) , 657-658
Zero risk for central line-associated bloodstream infections … is this realistic?*
- 1 February 2012
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 40 (2) , 657-658
Zero risk for central line-associated bloodstream infections … is this realistic?*
- Open Access
- 2 September 2011
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 53 (7) , 746-748
Reply to Renes et al
All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the
- 2 September 2011
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 53 (7) , 746-748
Open AccessReply to Renes et al
All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the
- Top Cited PapersOpen Access
- 1 May 2011
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 52 (9) , e162-e193
Guidelines for the Prevention of Intravascular Catheter-related Infections
These guidelines have been developed for healthcare personnel who insert intravascular catheters and for persons responsible for surveillance and control of infections in hospital, outpatient, and home healthcare settings. This report was prepared by a working group comprising members from professional organizations representing the disciplines of critical care medicine, infectious diseases, healthcare infection control, surgery, anesthesiology, interventional radiology, pulmonary medicine, pediatric medicine, and nursing. The working group was led by the Society of Critical Care Medicine (SCCM), in collaboration with the Infectious Diseases Society of America (IDSA), Society for Healthcare Epidemiology of America (SHEA), Surgical Infection Society (SIS), American College of Chest Physicians (ACCP), American Thoracic Society (ATS), American Society of Critical Care Anesthesiologists (ASCCA), Association for Professionals in Infection Control and Epidemiology (APIC), Infusion Nurses Society (INS), Oncology Nursing Society (ONS), American Society for Parenteral and Enteral Nutrition (ASPEN), Society of Interventional Radiology (SIR), American Academy of Pediatrics (AAP), Pediatric Infectious Diseases Society (PIDS), and the Healthcare Infection Control Practices Advisory Committee (HICPAC) of the Centers for Disease Control and Prevention (CDC) and is intended to replace the Guideline for Prevention of Intravascular Catheter-Related Infections published in 2002. These guidelines are intended to provide evidence-based recommendations for preventing intravascular catheter-related infections. Major areas of emphasis include 1) educating and training healthcare personnel who insert and maintain catheters; 2) using maximal sterile barrier precautions during central venous catheter insertion; 3) using a > 0.5% chlorhexidine skin preparation with alcohol for antisepsis; 4) avoiding routine replacement of central venous catheters as a strategy to prevent infection; and 5) using antiseptic/antibiotic impregnated short-term central venous catheters and chlorhexidine impregnated sponge dressings if the rate of infection is not decreasing despite adherence to other strategies (i.e, education and training, maximal sterile barrier precautions, and >0.5% chlorhexidine preparations with alcohol for skin antisepsis). These guidelines also emphasize performance improvement by implementing bundled strategies, and documenting and reporting rates of compliance with all components of the bundle as benchmarks for quality assurance and performance improvement.
- 1 May 2011
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 52 (9) , e162-e193
Top Cited PapersOpen AccessGuidelines for the Prevention of Intravascular Catheter-related Infections
These guidelines have been developed for healthcare personnel who insert intravascular catheters and for persons responsible for surveillance and control of infections in hospital, outpatient, and home healthcare settings. This report was prepared by a working group comprising members from professional organizations representing the disciplines of critical care medicine, infectious diseases, healthcare infection control, surgery, anesthesiology, interventional radiology, pulmonary medicine, pediatric medicine, and nursing. The working group was led by the Society of Critical Care Medicine (SCCM), in collaboration with the Infectious Diseases Society of America (IDSA), Society for Healthcare Epidemiology of America (SHEA), Surgical Infection Society (SIS), American College of Chest Physicians (ACCP), American Thoracic Society (ATS), American Society of Critical Care Anesthesiologists (ASCCA), Association for Professionals in Infection Control and Epidemiology (APIC), Infusion Nurses Society (INS), Oncology Nursing Society (ONS), American Society for Parenteral and Enteral Nutrition (ASPEN), Society of Interventional Radiology (SIR), American Academy of Pediatrics (AAP), Pediatric Infectious Diseases Society (PIDS), and the Healthcare Infection Control Practices Advisory Committee (HICPAC) of the Centers for Disease Control and Prevention (CDC) and is intended to replace the Guideline for Prevention of Intravascular Catheter-Related Infections published in 2002. These guidelines are intended to provide evidence-based recommendations for preventing intravascular catheter-related infections. Major areas of emphasis include 1) educating and training healthcare personnel who insert and maintain catheters; 2) using maximal sterile barrier precautions during central venous catheter insertion; 3) using a > 0.5% chlorhexidine skin preparation with alcohol for antisepsis; 4) avoiding routine replacement of central venous catheters as a strategy to prevent infection; and 5) using antiseptic/antibiotic impregnated short-term central venous catheters and chlorhexidine impregnated sponge dressings if the rate of infection is not decreasing despite adherence to other strategies (i.e, education and training, maximal sterile barrier precautions, and >0.5% chlorhexidine preparations with alcohol for skin antisepsis). These guidelines also emphasize performance improvement by implementing bundled strategies, and documenting and reporting rates of compliance with all components of the bundle as benchmarks for quality assurance and performance improvement.
- Top Cited PapersOpen Access
- 1 May 2011
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 52 (9) , 1087-1099
Summary of Recommendations: Guidelines for the Prevention of Intravascular Catheter-related Infections
These guidelines have been developed for healthcare personnel who insert intravascular catheters and for persons responsible for surveillance and control of infections in hospital, outpatient, and home healthcare settings. This report was prepared by a working group comprising members from professional organizations representing the disciplines of critical care medicine, infectious diseases, healthcare infection control, surgery, anesthesiology, interventional radiology, pulmonary medicine, pediatric medicine, and nursing. The working group was led by the Society of Critical Care Medicine (SCCM), in collaboration with the Infectious Diseases Society of America (IDSA), Society for Healthcare Epidemiology of America (SHEA), Surgical Infection Society (SIS), American College of Chest Physicians (ACCP), American Thoracic Society (ATS), American Society of Critical Care Anesthesiologists (ASCCA), Association for Professionals in Infection Control and Epidemiology (APIC), Infusion Nurses Society (INS), Oncology Nursing Society (ONS), American Society for Parenteral and Enteral Nutrition (ASPEN), Society of Interventional Radiology (SIR), American Academy of Pediatrics (AAP), Pediatric Infectious Diseases Society (PIDS), and the Healthcare Infection Control Practices Advisory Committee (HICPAC) of the Centers for Disease Control and Prevention (CDC) and is intended to replace the Guideline for Prevention of Intravascular Catheter-Related Infections published in 2002. These guidelines are intended to provide evidence-based recommendations for preventing intravascular catheter-related infections. Major areas of emphasis include 1) educating and training healthcare personnel who insert and maintain catheters; 2) using maximal sterile barrier precautions during central venous catheter insertion; 3) using a > 0.5% chlorhexidine skin preparation with alcohol for antisepsis; 4) avoiding routine replacement of central venous catheters as a strategy to prevent infection; and 5) using antiseptic/antibiotic impregnated short-term central venous catheters and chlorhexidine impregnated sponge dressings if the rate of infection is not decreasing despite adherence to other strategies (i.e, education and training, maximal sterile barrier precautions, and >0.5% chlorhexidine preparations with alcohol for skin antisepsis). These guidelines also emphasize performance improvement by implementing bundled strategies, and documenting and reporting rates of compliance with all components of the bundle as benchmarks for quality assurance and performance improvement.
- 1 May 2011
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 52 (9) , 1087-1099
Top Cited PapersOpen AccessSummary of Recommendations: Guidelines for the Prevention of Intravascular Catheter-related Infections
These guidelines have been developed for healthcare personnel who insert intravascular catheters and for persons responsible for surveillance and control of infections in hospital, outpatient, and home healthcare settings. This report was prepared by a working group comprising members from professional organizations representing the disciplines of critical care medicine, infectious diseases, healthcare infection control, surgery, anesthesiology, interventional radiology, pulmonary medicine, pediatric medicine, and nursing. The working group was led by the Society of Critical Care Medicine (SCCM), in collaboration with the Infectious Diseases Society of America (IDSA), Society for Healthcare Epidemiology of America (SHEA), Surgical Infection Society (SIS), American College of Chest Physicians (ACCP), American Thoracic Society (ATS), American Society of Critical Care Anesthesiologists (ASCCA), Association for Professionals in Infection Control and Epidemiology (APIC), Infusion Nurses Society (INS), Oncology Nursing Society (ONS), American Society for Parenteral and Enteral Nutrition (ASPEN), Society of Interventional Radiology (SIR), American Academy of Pediatrics (AAP), Pediatric Infectious Diseases Society (PIDS), and the Healthcare Infection Control Practices Advisory Committee (HICPAC) of the Centers for Disease Control and Prevention (CDC) and is intended to replace the Guideline for Prevention of Intravascular Catheter-Related Infections published in 2002. These guidelines are intended to provide evidence-based recommendations for preventing intravascular catheter-related infections. Major areas of emphasis include 1) educating and training healthcare personnel who insert and maintain catheters; 2) using maximal sterile barrier precautions during central venous catheter insertion; 3) using a > 0.5% chlorhexidine skin preparation with alcohol for antisepsis; 4) avoiding routine replacement of central venous catheters as a strategy to prevent infection; and 5) using antiseptic/antibiotic impregnated short-term central venous catheters and chlorhexidine impregnated sponge dressings if the rate of infection is not decreasing despite adherence to other strategies (i.e, education and training, maximal sterile barrier precautions, and >0.5% chlorhexidine preparations with alcohol for skin antisepsis). These guidelines also emphasize performance improvement by implementing bundled strategies, and documenting and reporting rates of compliance with all components of the bundle as benchmarks for quality assurance and performance improvement.
- Top Cited Papers
- 1 May 2011
- Published by Elsevier in American Journal of Infection Control
- Vol. 39 (4) , S1-S34
Guidelines for the prevention of intravascular catheter-related infections
- 1 May 2011
- Published by Elsevier in American Journal of Infection Control
- Vol. 39 (4) , S1-S34
Top Cited PapersGuidelines for the prevention of intravascular catheter-related infections